Erythromycin monohydrate is a specific crystalline form of erythromycin, a widely utilized macrolide antibiotic. It is prescribed to treat a broad spectrum of bacterial infections by binding to bacterial ribosomes and inhibiting the production of vital proteins necessary for bacterial growth and survival. It is grouped under the following drug class(es): Macrolides. Its therapeutic use is listed as acne agents and anti-infectives. The directory classifies it as a commercial API. Other names for this substance include (-)-Erythromycin hydrate and Erythromycindihydrate. Its PubChem CID is 88122.
Erythromycin monohydrate
| CAS No | 67733-56-6 |
|---|---|
| Molecular Formula | C37H69NO14 |
| Molecular Weight | 751.90 g/mol |
| Synonyms | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Erythromycin monohydrate is a specific crystalline form of erythromycin, a widely utilized macrolide antibiotic. It is prescribed to treat a broad spectrum of bacterial infections by binding to bacterial ribosomes and inhibiting the production of vital proteins necessary for bacterial growth and survival.
The listed CAS number is 67733-56-6.
The listed molecular formula is C37H69NO14.
The listed molecular weight is 751.90 g/mol.
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;hydrate.
The source lists (-)-Erythromycin hydrate and Erythromycindihydrate.